Farrant Elizabeth
New Path Molecular Research Ltd, Building 580, Babraham Research Campus, Cambridge CB22 3AT, U.K.
ACS Med Chem Lett. 2020 Jul 16;11(8):1506-1513. doi: 10.1021/acsmedchemlett.0c00292. eCollection 2020 Aug 13.
Since the 1990s, concerted attempts have been made to improve the efficiency of medicinal chemistry synthesis tasks using automation. Although impacts have been seen in some tasks, such as small array synthesis and reaction optimization, many synthesis tasks in medicinal chemistry are still manual. As it has been shown that synthesis technology has a large effect on the properties of the compounds being tested, this review looks at recent research in automation relevant to synthesis in medicinal chemistry. A common theme has been the integration of tasks, as well as the use of increased computing power to access complex automation platforms remotely and to improve synthesis planning software. However, there has been more limited progress in modular tools for the medicinal chemist with a focus on autonomy rather than automation.
自20世纪90年代以来，人们一直在协同努力，通过自动化来提高药物化学合成任务的效率。尽管在一些任务中已见成效，如小阵列合成和反应优化，但药物化学中的许多合成任务仍需人工操作。鉴于已表明合成技术对所测试化合物的性质有很大影响，本综述着眼于与药物化学合成相关的自动化方面的最新研究。一个共同的主题是任务整合，以及利用增强的计算能力来远程访问复杂的自动化平台并改进合成规划软件。然而，针对药物化学家的模块化工具，在侧重于自主性而非自动化方面进展较为有限。
